Home › Funds › Sarissa Capital Management LP › BHVN
Sarissa Capital Management LP position in BHVN
BIOHAVEN LTD · Health Care
Sarissa Capital Management LP reported holding 582,312 shares of BHVN (BIOHAVEN LTD) in its Q2 2026 13F filing — a position valued at US$8.7M, representing 4.87% of its reported portfolio and ranking #7 among its reported holdings. Sarissa Capital Management LP has disclosed BHVN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Sarissa Capital Management LP's BHVN position evolved
Sarissa Capital Management LP first disclosed a stake in BHVN in Q4 2025 at 513,184 shares (US$5.8M). The position peaked in Q2 2026 at 582,312 shares, worth US$8.7M. Across 3 filings, Sarissa Capital Management LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 582,312 shares valued at US$8.7M — an increase of 19,128 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 513.18K | $5.79M | New |
| Q1 2026 | 563.18K | $4.76M | Add |
| Q2 2026 | 582.31K | $8.66M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BHVN and 13F data
BHVN (BIOHAVEN LTD) is a Health Care company. 30 other funds we track also report a position in BHVN — the largest reported positions include MONTANOVA CAPITAL, LLC (US$153.1M), INFINITUM ASSET MANAGEMENT, LLC (US$93.0M), Royalty Pharma Sub-Manager, LLC (US$43.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BHVN
- MONTANOVA CAPITAL, LLC 10.29M sh · $153.07M · Q2 2026
- INFINITUM ASSET MANAGEMENT, LLC 6.25M sh · $93.00M · Q2 2026
- Royalty Pharma Sub-Manager, LLC 2.94M sh · $43.70M · Q2 2026
- Cormorant Asset Management, LP 2.61M sh · $38.84M · Q2 2026
- Knoll Capital Management, LLC 2.35M sh · $35.01M · Q2 2026
- TCG Crossover Management, LLC 1.78M sh · $26.49M · Q2 2026
- ARS Investment Partners, LLC 1.37M sh · $20.45M · Q2 2026
More on Sarissa Capital Management LP
FAQ
How long has Sarissa Capital Management LP held BHVN?
Sarissa Capital Management LP has disclosed BHVN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Sarissa Capital Management LP's current position in BHVN?
As of Q2 2026, Sarissa Capital Management LP holds 582.31K shares of BHVN (BIOHAVEN LTD), valued at $8.66M, representing 4.87% of its reported portfolio and ranking #7.
Has Sarissa Capital Management LP been buying or selling BHVN?
In the latest 13F filing (Q2 2026), Sarissa Capital Management LP increased its position in BHVN. The position peaked in Q2 2026 at 582.31K shares.
Which other funds hold BHVN?
Other major institutional holders of BHVN include MONTANOVA CAPITAL, LLC, INFINITUM ASSET MANAGEMENT, LLC, Royalty Pharma Sub-Manager, LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.